Rabeprazole Sodium (rabeprazole) NDC 65162-724

NDC codes

FDA NDC Directory

Product NDC (as listed)65162-724Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65162-0724Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65162-724-03	65162072403	30 TABLET, DELAYED RELEASE in 1 BOTTLE (65162-724-03)Marketed from Oct 1, 2015
65162-724-09	65162072409	90 TABLET, DELAYED RELEASE in 1 BOTTLE (65162-724-09)Marketed from Oct 1, 2015
65162-724-11	65162072411	1000 TABLET, DELAYED RELEASE in 1 BOTTLE (65162-724-11)Marketed from Oct 1, 2015
65162-724-50	65162072450	500 TABLET, DELAYED RELEASE in 1 BOTTLE (65162-724-50)Marketed from Oct 1, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rabeprazole Sodium
Generic name (nonproprietary): rabeprazole
Active ingredients: Rabeprazole sodium — 20 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Amneal Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204179
Marketing start: Oct 1, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 65162-724_f02b0373-dbac-4842-bf97-3352b8c74089SPL ID f02b0373-dbac-4842-bf97-3352b8c74089SPL set ID 951caefe-6e18-48ff-9567-beb545b09c25RxCUI 854868UNII 3L36P16U4RUPC 0365162724035
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465162072403 followed by a unit qualifier and the quantity

Package 65162-0724-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2023.

Indications (excerpt from the label)

Rabeprazole sodium delayed-release tablets are a proton pump inhibitor (PPI) indicated in adults for: Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD). ( 1.1 ) Maintenance of Healing of Erosive or Ulcerative GERD. ( 1.2 ) Treatment of Symptomatic GERD. ( 1.3 ) Healing of Duodenal Ulcers. ( 1.4 ) Helicobacter pylori Eradication to Reduce Risk of Duodenal Ulcer Recurrence. ( 1.5 ) Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome. ( 1.6 ) In adolescent patients 12 years of age and older for: Short-term Treatment of Symptomatic GERD. ( 1.7 ) 1.1 Healing of Erosive or Ulcerative GERD in Adults Rabeprazole sodium delayed-release table…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)